Second Sight Medical Products, Inc.
(NASDAQ CM: EYES)
Rigrodsky Law, P.A. is investigating Second Sight Medical Products, Inc. (“Second Sight”) regarding possible breaches of fiduciary duties and other violations of law related to Second Sight’s agreement to be acquired by Nano Precision Medical, Inc. (“Nano”). Under the terms of the agreement, Nano’s shareholders will receive a total of 134 million shares of Second Sight common stock.